These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. Choi SH; Woo JH; Lee JE; Park SJ; Choo EJ; Kwak YG; Kim MN; Choi MS; Lee NY; Lee BK; Kim NJ; Jeong JY; Ryu J; Kim YS J Antimicrob Chemother; 2005 Dec; 56(6):1111-4. PubMed ID: 16244086 [TBL] [Abstract][Full Text] [Related]
48. Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria. Piddock LJ; Johnson MM; Webber MA J Antimicrob Chemother; 2003 Sep; 52(3):500-2. PubMed ID: 12917244 [TBL] [Abstract][Full Text] [Related]
49. The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts. Crumplin GC; Smith JT J Antimicrob Chemother; 1981 Apr; 7(4):379-88. PubMed ID: 7019186 [No Abstract] [Full Text] [Related]
50. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. Cesaro A; Bettoni RR; Lascols C; Mérens A; Soussy CJ; Cambau E J Antimicrob Chemother; 2008 May; 61(5):1007-15. PubMed ID: 18325893 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. Costa D; Poeta P; Sáenz Y; Coelho AC; Matos M; Vinué L; Rodrigues J; Torres C Vet Microbiol; 2008 Feb; 127(1-2):97-105. PubMed ID: 17870255 [TBL] [Abstract][Full Text] [Related]
53. [Antibacterial activity of nalidixic acid (WIN 18320) on various strains of Gram-negative organisms]. Callao V; Ramos A Microbiol Esp; 1966; 19(2):173-82. PubMed ID: 5974262 [No Abstract] [Full Text] [Related]
54. "Reversion" of DNA polymerase-deficient Escherichia coli. D'Alisa RM; Carden GA; Carr HS; Rosenkranz HS Mol Gen Genet; 1971; 110(1):23-6. PubMed ID: 4927441 [No Abstract] [Full Text] [Related]
55. Resistance to ultraviolet-induced mutagenesis in Proteus. Schwarzhoff R; Santhanam U Experientia; 1981; 37(9):965-6. PubMed ID: 7028504 [No Abstract] [Full Text] [Related]
56. Mutants of Klebsiella pneumoniae resistant to several antibiotics. Smith HW Nature; 1976 Jan; 259(5541):307-8. PubMed ID: 765837 [No Abstract] [Full Text] [Related]
57. Enhancement by nalidixic acid of the thermal susceptibility of the Ts-7 mutant of Escherichia coli TAU-bar. Nishida M; Mishima Y; Kawada J; Yielding KL Antimicrob Agents Chemother; 1975 Sep; 8(3):384-6. PubMed ID: 1101825 [TBL] [Abstract][Full Text] [Related]
58. Adaptive drug resistance in Gram-negative bacteria. Dean AC Proc R Soc Med; 1971 May; 64(5):534-7. PubMed ID: 5576917 [No Abstract] [Full Text] [Related]
59. [Isolation of Chlamydomonas reinhardtii mutants resistant to nalidixic acid]. Robreau G; Jensen G; Le Gal Y C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(16):1699-702. PubMed ID: 4204876 [No Abstract] [Full Text] [Related]
60. Antibacterially active substances. IV. Microbial hydroxylation of nalidixic acid. Capek A; Simek A; Svátek E; Budĕsínský M Folia Microbiol (Praha); 1969; 14(6):557-9. PubMed ID: 4906620 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]